← Leaderboards
H William Kelly
University Of New Mexico
$2,191,228
Attributed
$2,191,228
Total exposure
12
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $332.2K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,191,228 · 12
By mechanism
M01$1,175,614 · 11
U01$1,015,614 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of New Mexico
Same institution · by research overlap
- Robert Katz$89,732
- Bennie Mc Williams$609,690
- Paul B Roth$15,333,145
- Gary Allen Rosenberg$25,012,030
- Diane Goade$1,196,947
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- Scott T Weiss · University Of California, San Diego$98,211,117
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Fernando D Martinez · University Of Arizona$66,357,737
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
Research focus
AsthmaClinical ResearchHuman SubjectAdultChildhood AsthmaGrowthChildProgramsCorticosteroidsCohortHuman Therapy EvaluationChildhoodChild (0-11)Follow-UpAdrenal Cortex HormonesBreathingLungRespiratory PhysiologyComputer Retrieval Of Information On Scientific Projects DatabaseInstitutionGrantHeightAntigen Antibody ReactionDrug Screening /Evaluation
Grant awards (21)
CHILDHOOD ASTHMA MANAGEMENT PROGRAM CONTINUATION STUDY PHASE/3$37,214
M01 · FY2010 · RR · contact PI
CAMP Continuation Study/Phase 3$93,106
U01 · FY2009 · HL · contact PI
CHILDHOOD ASTHMA MANAGEMENT PROGRAM CONTINUATION STUDY PHASE/3$54,363
M01 · FY2009 · RR · contact PI
CAMP Continuation Study/Phase 3$146,552
U01 · FY2008 · HL · contact PI
CLINICAL TRIAL: CHILDHOOD ASTHMA MANAGEMENT PROGRAM CONTINUATION STUDY PHASE 2 ($80,923
M01 · FY2008 · RR · contact PI
CAMP Continuation Study/Phase 3$122,432
U01 · FY2007 · HL · contact PI
CHILDHOOD ASTHMA MANAGEMENT PROGRAM CONTINUATION STUDY PHASE 2 (CAMPCS/2)$64,492
M01 · FY2007 · RR · contact PI
CAMP Continuation Study/Phse 2 (CAMPCS/2)$205,109
U01 · FY2006 · HL · contact PI
CHILDHOOD ASTHMA MANAGEMENT PROGRAM CONTINUATION STUDY PHASE 2 (CAMPCS/2)$49,638
M01 · FY2006 · RR · contact PI
CAMP Continuation Study/Phse 2 (CAMPCS/2)$171,226
U01 · FY2005 · HL
CHILDHOOD ASTHMA MANAGEMENT PROGRAM CONTINUATION STUDY (CAMPCS)$79,610
M01 · FY2005 · RR
CHILDHOOD ASTHMA MANAGEMENT PROGRAM CONTINUATION STUDY PHASE 2 (CAMPCS/2)$70,145
M01 · FY2005 · RR
PROSPECTIVE STUDY OF LORAZEPAM WITHDRAWAL IN CRITICALLY ILL CHILDREN$11,190
M01 · FY2005 · RR
CAMP Continuation Study/Phse 2 (CAMPCS/2)$164,108
U01 · FY2004 · HL
Childhood Asthma Management Program Continuation Study (CAMPCS)$140,224
M01 · FY2004 · RR
Childhood Asthma Management Program Asthma Genetics$558
M01 · FY2004 · RR
CAMP Continuation Study/Phse 2 (CAMPCS/2)$113,081
U01 · FY2003 · HL
COMPARISON OF SYSTEMIC EFFECTS OF INHALED CORTICOSTEROIDS IN CHILDREN$282,412
M01 · FY2002 · RR
COMPARISON OF SYSTEMIC EFFECTS OF INHALED CORTICOSTEROIDS IN CHILDREN$282,412
M01 · FY2001 · RR
COMPARISON OF SYSTEMIC EFFECTS OF INHALED CORTICOSTEROIDS IN CHILDREN$22,433
M01 · FY2000 · RR
COMPARISON OF SYSTEMIC EFFECTS OF INHALED CORTICOSTEROIDS IN CHILDREN$0
M01 · FY2000 · RR